You are here: Home pathway Area of law pathway Prempro

Defective Drugs Lawyers and Attorneys Legal Help


There is approximately 6 million women taking the prescription medication Prempro nationwide . Prempro is a leading Hormone Replacement Therapy (HRT) medication, which combines estrogen and progestin into one medication. It is prescribed to treat women suffering menopausal symptoms that include mood swings, hot flashes, night sweats, vaginal dryness and osteoporosis.

It was thought that HRT could reduce the risk of osteoporosis and heart complications in women, when first introduced. However, in July 2002, the National Institute of Health (NIH) terminated a major clinical study of 16,000 women based on alarming preliminary findings . The facts suggested that after only one year on Prempro, an otherwise healthy woman faced increased risk of

  • Heart attack (by 29%)
  • Breast cancer (by 24%)
  • Blood clots (by 200%)
  • Stroke (by 41%).
  • The National Cancer Institute also reported in another study that ovarian cancer risk in postmenopausal women increased to 220% if they took estrogen for more than 20 years.

For nearly 40 years, women have been encouraged to take medications like Prempro to ease menopausal symptoms - yet these medications were suggested on untrustworthy medical evidence . Wyeth pharmaceutical company, which is the manufacturer of Prempro, has no plans to evoke the drug. Prempro earns almost $1.4 billion in income to Wyeth's coffer every year.

We believe that drug companies who place profit above people must be held accountable for their negligence and the damage they cause to innocent victim's lives.

In reaction to the Prempro controversy, Wyeth has distributed new guidelines that warn against long-term use and has cut the drug's suggested dosage by half. Regrettably, it may be too late for the many women who have endured adverse effects. Dangerous prescription medications have been marketed without thorough testing or have insufficient warning labels. Even more disturbing is the reality that the drug producer may fund many of the tests required by the FDA.